Roszet Shortage Update for 2026

If you've been searching for Roszet (Ezetimibe/Rosuvastatin) at your pharmacy, here's what you need to know: Roszet is no longer just in short supply — it has been permanently discontinued. Althera Life Sciences, the manufacturer, stopped producing all formulations of Roszet. This means there is no remaining supply in the distribution pipeline, and no date for the drug to return.

We know how stressful it can be when a medication you depend on suddenly disappears. This article will give you a clear update on the situation and help you figure out your next steps.

Is Roszet Still in Shortage?

Technically, Roszet is no longer considered to be in a drug shortage. A shortage implies the drug is temporarily unavailable but expected to return. In Roszet's case, the situation is worse: all formulations have been permanently discontinued as of 2025.

This includes all four available strengths:

• Ezetimibe 10 mg / Rosuvastatin 5 mg
• Ezetimibe 10 mg / Rosuvastatin 10 mg
• Ezetimibe 10 mg / Rosuvastatin 20 mg
• Ezetimibe 10 mg / Rosuvastatin 40 mg

No generic version of the combination tablet exists, and one isn't expected until approximately 2033 based on current patent protections.

Why Is Roszet Hard to Find?

Several factors contributed to Roszet's disappearance from the market:

• Limited commercial uptake: Because generic Rosuvastatin and generic Ezetimibe were already available as separate, affordable pills, many insurers required patients to try those first. This limited Roszet's market share.
• Insurance barriers: Many plans required prior authorization or step therapy before covering brand Roszet, making it harder for patients to access.
• Regulatory scrutiny: The FDA issued an untitled letter to Althera regarding promotional materials for Roszet, adding to business challenges.
• Manufacturer decision: Ultimately, Althera Life Sciences chose to discontinue the product.

For a deeper dive, read our article on why Roszet is so hard to find.

What Does Roszet Cost in 2026?

Since Roszet is no longer manufactured, the question of its price is mostly academic. However, for context:

• Brand Roszet previously cost between $150 and $350 per 30 tablets depending on the strength and pharmacy.
• Generic alternatives (separate pills) cost significantly less: generic Rosuvastatin runs about $10 to $30 per month, and generic Ezetimibe costs about $10 to $25 per month.

So switching to the generic components can save you $100 to $300 per month. For detailed savings tips, see our guide on how to save money on Roszet alternatives.

New Options and Alternatives

Even though Roszet is gone, cholesterol-lowering treatment has not changed significantly. The same active ingredients are available, and you have multiple paths forward:

• Generic Rosuvastatin + Generic Ezetimibe: The most direct replacement. Same ingredients, two pills, about $20 to $55 per month.
• Generic Vytorin (Ezetimibe/Simvastatin): A single combination pill using a different statin. Costs about $15 to $40 per month.
• Atorvastatin + Ezetimibe: A widely used combination with excellent LDL-lowering results. About $15 to $45 per month as separate generics.

Read our full breakdown of alternatives to Roszet.

How to Find Your Medication in Stock

While Roszet itself is no longer available, finding the generic components is easy:

1. Visit Medfinder and search for "Rosuvastatin" or "Ezetimibe"
2. Enter your zip code to find nearby pharmacies with stock
3. Compare prices across pharmacies to get the best deal

For step-by-step help, see our guide on how to check pharmacy availability.

Final Thoughts

The Roszet discontinuation is permanent, but your cholesterol management doesn't have to suffer. The same active ingredients are available in generic form at a lower cost. Contact your doctor to get updated prescriptions, and use Medfinder to find the best availability and prices near you.

Don't skip your medication — keeping your LDL cholesterol in check is one of the most important things you can do for your heart health.